trending Market Intelligence /marketintelligence/en/news-insights/trending/ruAV2-hNCjzbtQA5Pvuwdg2 content esgSubNav
In This List

Cloud Security fiscal Q3 loss narrows YOY

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix

Blog

Using ESG Analysis to Support a Sustainable Future


Cloud Security fiscal Q3 loss narrows YOY

US-China Biomedical Technology Inc. said its normalized net income for the fiscal third quarter ended Nov. 30, 2015, came to a loss of $7,790, compared with a loss of $35,640 in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

Reported net income came to a loss of $12,460, or a loss of 0 cents per share, compared to a loss of $58,300, or a loss of 6 cents per share, in the year-earlier period.